Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
U6 small nuclear RNA 580, pseudogene (RNU6-580P) is a putative genomic DNA sequence related to the functional U6 small nuclear RNA (snRNA) gene family, but has accumulated mutations or other changes that prevent it from encoding a functional snRNA molecule[3][4]. U6 snRNA is a key structural RNA in the spliceosome complex, required for the splicing of pre-mRNA in eukaryotic nuclei[3][5]. However, pseudogene copies such as RNU6-580P serve no known biological function and are considered "genomic fossils"[4][6]. Unlike functional U6 snRNA genes, which are critical for intron removal in transcripts, RNU6-580P is not transcribed into a functional molecule, does not participate in RNA splicing, and has no characterized impact on disease or therapy. While some pseudogenes may exert regulatory effects in rare instances (such as serving as ceRNAs or microRNA sponges), there is no evidence that RNU6-580P functions in this manner[4]. As a result, it is not considered a molecular target for therapeutic intervention. This target is best categorized as a non-functional pseudogene rather than a druggable target or receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U6 small nuclear RNA 580, pseudogene (RNU6-580P).